p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

被引:23
|
作者
Cancino, Gonzalo I. [1 ,2 ]
Miller, Freda D. [2 ,3 ,4 ]
Kaplan, David R. [1 ,3 ]
机构
[1] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada
[2] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[4] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
p73; p53; family; Tau phosphorylation; Pin1; Alzheimer's disease; Aging; Neurodegeneration; GSK-3; beta; c-Abl; Cdk5; Tauopathy; Paired helical filaments; TgCRND8; PROLYL ISOMERASE PIN1; C-ABL; NEURONAL SURVIVAL; P53; FAMILY; PHOSPHORYLATION; CDK5; MAINTENANCE; PATHOLOGY; BRAIN; MICE;
D O I
10.1016/j.neurobiolaging.2012.04.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Haploinsufficiency for the p53 family member p73 causes behavioral and neuroanatomical correlates of neurodegeneration in aging mice, including the appearance of aberrant phospho-tau-positive aggregates. Here, we show that these aggregates and tau hyperphosphorylation, as well as a generalized dysregulation of the tau kinases GSK3 beta, c-Abl, and Cdk5, occur in the brains of aged p73+/- mice. To investigate whether p73 haploinsufficiency therefore represents a general risk factor for tau hyperphosphorylation during neurodegeneration, we crossed the p73+/- mice with 2 mouse models of neurodegeneration, TgCRND8+/empty set mice that express human mutant amyloid precursor protein, and Pin1-/- mice. We show that haploinsufficiency for p73 leads to the early appearance of phospho-tau-positive aggregates, tau hyperphosphorylation, and activation of GSK3 beta, c-Abl, and Cdk5 in the brains of both of these mouse models. Moreover, p73+/-; TgCRND8+/empty set mice display a shortened lifespan relative to TgCRND8+/empty set mice that are wild type for p73. Thus, p73 is required to protect the murine brain from tau hyperphosphorylation during aging and degeneration. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 399
页数:13
相关论文
共 50 条
  • [21] ALWPs Improve Cognitive Function and Regulate Aβ Plaque and Tau Hyperphosphorylation in a Mouse Model of Alzheimer's Disease
    Nam, Youngpyo
    Joo, Bitna
    Lee, Ju-Young
    Han, Kyung-Min
    Ryu, Ka-Young
    Koh, Young Ho
    Kim, Jeongyeon
    Koo, Ja Wook
    We, Young-Man
    Hoe, Hyang-Sook
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [22] Brain somatic mutations associated with aging contribute to dysregulation of Tau phosphorylation in Alzheimer's disease
    Park, J.
    Lee, J.
    Jung, E.
    Kim, M.
    Kim, I.
    Son, H.
    Kim, S.
    Kim, S.
    Park, Y.
    Mook-Jung, I.
    Yu, S.
    Lee, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1085 - 1085
  • [23] Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts
    Vardarajan, Badri
    Vergote, David
    Tissir, Fadel
    Logue, Mark
    Yang, Jing
    Daude, Nathalie
    Ando, Kunie
    Rogaeva, Ekaterina
    Lee, Joseph
    Cheng, Rong
    Brion, Jean-Pierre
    Ghani, Mahdi
    Shi, Beipei
    Baldwin, Clinton T.
    Kar, Satyabrata
    Mayeux, Richard
    Fraser, Paul
    Goffinet, Andre M.
    St George-Hyslop, Peter
    Farrer, Lindsay A.
    Westaway, David
    MOLECULAR NEURODEGENERATION, 2013, 8
  • [24] Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
    Fossati, Silvia
    Ramos Cejudo, Jaime
    Debure, Ludovic
    Pirraglia, Elizabeth
    Sone, Je Yeong
    Li, Yi
    Chen, Jingyun
    Butler, Tracy
    Zetterberg, Henrik
    Blennow, Kaj
    de Leon, Mony J.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 483 - 492
  • [25] Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts
    Badri Vardarajan
    David Vergote
    Fadel Tissir
    Mark Logue
    Jing Yang
    Nathalie Daude
    Kunie Ando
    Ekaterina Rogaeva
    Joseph Lee
    Rong Cheng
    Jean-Pierre Brion
    Mahdi Ghani
    Beipei Shi
    Clinton T Baldwin
    Satyabrata Kar
    Richard Mayeux
    Paul Fraser
    André M Goffinet
    Peter St George-Hyslop
    Lindsay A Farrer
    David Westaway
    Molecular Neurodegeneration, 8
  • [26] Tau kinase inhibition for treatment of Alzheimer's disease
    Bhat, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S119 - S119
  • [27] Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease
    Jian-Zhi Wang
    Zhi-Hao Wang
    Qing Tian
    Neuroscience Bulletin, 2014, 30 (02) : 359 - 366
  • [28] Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease
    Wang, Jian-Zhi
    Wang, Zhi-Hao
    Tian, Qing
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 359 - 366
  • [29] Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
    Anton-Fernandez, Alejandro
    Aparicio-Torres, Guillermo
    Tapia, Silvia
    DeFelipe, Javier
    Munoz, Alberto
    NEUROBIOLOGY OF DISEASE, 2017, 97 : 11 - 23
  • [30] Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
    De Felice, Fernanda G.
    Wu, Diana
    Lambert, Mary P.
    Fernandez, Sara J.
    Velasco, Pauline T.
    Lacor, Pascale N.
    Bigio, Eileen H.
    Jerecic, Jasna
    Acton, Paul J.
    Shughrue, Paul J.
    Chen-Dodson, Elizabeth
    Kinney, Gene G.
    Klein, William L.
    NEUROBIOLOGY OF AGING, 2008, 29 (09) : 1334 - 1347